SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-000820
Filing Date
2018-01-22
Accepted
2018-01-22 08:30:33
Documents
4
Period of Report
2018-01-22
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29255
2 ex99-1.htm EX-99.1 17882
3 ex99-1_001.jpg GRAPHIC 4215
4 ex99-1_002.jpg GRAPHIC 16279
  Complete submission text file 0001493152-18-000820.txt   76696
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 18538850
SIC: 2836 Biological Products, (No Diagnostic Substances)